Antihypertensive Efficacy and Safety of Candesartan/HCT 32/12.5 and 32/25 mg in Comparison With Candesartan 32 mg

PHASE3CompletedINTERVENTIONAL
Enrollment

1,979

Participants

Timeline

Start Date

September 30, 2006

Primary Completion Date

August 31, 2007

Study Completion Date

October 31, 2007

Conditions
Hypertension
Interventions
DRUG

Candesartan cilexetil

32mg oral

DRUG

Hydrochlorothiazide

12.5 mg oral

DRUG

Hydrochlorothiazide

25 mg oral

Trial Locations (132)

Unknown

Research Site, Aalborg

Research Site, Ballerup Municipality

Research Site, Copenhagen

Research Site, Frederiksberg

Research Site, Herlev

Research Site, Vejle

Research Site, Pärnu

Research Site, Tallinn

Research Site, Tartu

Research Site, Võru

Research Site, Albens

Research Site, Arras

Research Site, Béziers

Research Site, Broglie

Research Site, Chartres

Research Site, Gémenos

Research Site, Hinx

Research Site, Husseren-Wesserling

Research Site, Labarthe-sur-Lèze

Research Site, Rosiers-d'Égletons

Research Site, Seraincourt

Research Site, Strasbourg

Research Site, Tours

Research Site, Vourey

Research Site, Augsburg

Research Site, Bad Krozingen

Research Site, Bad Segeberg

Research Site, Berlin

Research Site, Bochum

Research Site, Cloppenburg

Research Site, Cologne

Research Site, Dresden

Research Site, Erlangen

Research Site, Essen

Research Site, Frankfurt

Research Site, Goch

Research Site, Großheirath

Research Site, Hamburg

Research SIte, Hann

Research Site, Hermaringen

Research Site, Herne

Research Site, Karlsruhe

Research Site, Kiel

Research Site, Kippenheim

Research Site, Künzing

Research Site, Mannheim

Research Site, München

Research Site, Nuremberg

Research Site, Riesa

Research Site, Rodgau-dudenhofen

Research Site, Schwerin

Research Site, Siegen

Research Site, Steinfurt

Research Site, Straßkirchen

Research Site, Tübingen

Research Site, Werne

Research Site, Witten

Research Site, Kaunas

Research Site, Klaipėda

Research Site, Panevezys

Research Site, Šiauliai

Research Site, Vilnius

Research Site, 's-Gravenzande

Research Site, 's-Hertogenbosch

Research Site, Bennebroek

Research Site, Deurne

Research Site, Echt

Research Site, Ermelo

Research Site, Hengelo

Research Site, Hoogvliet

Research Site, Lichtenvoorde

Research Site, Losser

Research Site, Musselkanaal

Research Site, Oude Pekela

Research Site, Rijswijk

Research Site, Roelofarendsveen

Research Site, Rotterdam

Research Site, The Hague

Research Site, Volendam

Research Site, Woerden

Research Site, Zaandam

Research Site, Chrzanów

Research Site, Elblag

Research Site, Gdansk

Research Site, Gdynia

Research Site, Katowice

Research Site, Lodz

Research Site, Oława

Research Site, Poznan

Research Site, Płock

Research Site, Skierniewice

Research Site, Szczecin

Research Site, Belgrade

Research Site, Niska Banja

Research Site, Nis

Research Site, Sremska Kamenica

Research Site, Zemun

Research Site, Boden

Research Site, Gävle

Research Site, Gothenburg

Research Site, Linköping

Research Site, Malmo

Research Site, Motala

Research Site, Örebro

Research Site, Skellefteå

Research Site, Uppsala

Research Site, Chenoutsy

Research Site, Dnipro

Research Site, Kharkiv

Research Site, Kyiv

Research Site, Lviv

Research Site, Odesa

Research Site, Addlestone

Research Site, Ashford

Research Site, Ayrshire

Research Site, Burbage

Research Site, Cheadle

Research Site, Chesterfield

Research Site, Coventry

Research Site, Ely

Research Site, FIFE

Research Site, Glasgow

Research Site, Harrow

Research Site, Hastings

Research Site, Helensburgh

Research Site, Morriston

Research Site, Motherwell

Research Site, Newton Mearns

Research Site, Northwood Middlesex

Research Site, Paignton

Research Site, Royal Leamington Spa

Research Site, Wokingham

Sponsors

Lead Sponsor

All Listed Sponsors
lead

AstraZeneca

INDUSTRY